HomeCRXM • OTCMKTS
add
Gene Biotherapeutics Inc
Previous close
$0.00
Market cap
60.00 USD
Avg Volume
6.68K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2020info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.26M | 50.80% |
Net income | -517.90K | -159.76% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.26M | -61.83% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2020info | Y/Y change |
|---|---|---|
Cash and short-term investments | 386.03K | 96,406.75% |
Total assets | 566.98K | 1,500.06% |
Total liabilities | 5.14M | 5.12% |
Total equity | -4.57M | — |
Shares outstanding | 64.93M | — |
Price to book | -0.00 | — |
Return on assets | -261.90% | — |
Return on capital | 22.42% | — |
Cash Flow
Net change in cash
| (USD) | 2020info | Y/Y change |
|---|---|---|
Net income | -517.90K | -159.76% |
Cash from operations | -1.13M | -726.03% |
Cash from investing | -3.43K | — |
Cash from financing | 1.52M | 2,645.08% |
Net change in cash | 385.63K | 571.92% |
Free cash flow | -707.67K | 51.75% |
About
Founded
2003
Headquarters
Website
Employees
3
